Monthly Prescribing Reference

Adalimumab-adbm Injection, an Interchangeable Biosimilar to Humira, Now Available

Adalimumab-adbm injection, a biosimilar to Humira ® (adalimumab), has been made available by Boehringer Ingelheim. Adalimumab-adbm injection is an interchangeable biosimilar and can be substituted for ...
Nasdaq

Alvotech and Teva Announce U.S. Approval of SIMLANDI® (adalimumab-ryvk) injection, the first interchangeable high-concentration, citrate-free biosimilar to Humira®

REYKJAVIK, Iceland and PARSIPPANY, N.J., Feb. 24, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO) and Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical ...
Healthline

Biosimilar Drugs to Humira Are Arriving: Why Prices Won't Be Significantly Lower

Share on Pinterest The drug Humira is used to treat several types of arthritis. Eclipse Images/Getty Images The patent has finally expired for Humira, the biologic drug used to treat arthritis, ...
Healio

FDA approves Simlandi as third interchangeable Humira biosimilar

Please provide your email address to receive an email when new articles are posted on . Simlandi is the first interchangeable, citrate-free Humira biosimilar available in a high concentration. The ...